Inflammatory bowel diseases usually come with associated complications such as inflammation of the joints, eye, skin, colon cancer, ulcers, and malnutrition. It can be treated typically by using drug therapy methods such as immune system antibiotics and suppressors, anti-inflammatory drugs, lifestyle management, and surgery. The rising prevalence of inflammatory problems is anticipated to boost the global “inflammatory bowel diseases therapeutics market” says Fortune Business Insights in their recent report.

The study conducted on inflammatory bowel diseases therapeutics market by Fortune Business Insights is titled, “Inflammatory Bowe Diseases Therapeutics Market Size, Share and Global Trends by Product (TNF inhibitors, Aminosalicylates, Immunomodulators, Corticosteroids, Others), By Disease Indication (Crohn’s Disease, Ulcerative Colitis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Geography Forecast till 2026”. According to this study, the market can be is categorized on the basis of various factors such as product, diseases indication, distribution channel, and geography Forecast till 2026”. According to this study, the market can be is categorized on the basis of various factors such as product, diseases indication, distribution channel, and geography. The market is currently prognosticated to generate high revenue from immunomodulators segment based on product. Additionally, the increasing prevalence of ulcerative colitis, based on disease indication segment is anticipated to hold a considerable share in the market by the end of 2026.

The report on market focusses on various all factors influencing the growth of the market with interesting insights. All iInformation presented in the report is gathered from primary and secondary research methods. The interesting insights provided in the report will help the market vendors to accordingly invest in new plans for better revenue generation in the near future.

Request a Sample Copy of the Research Report:

Increasing Prevalence of Crohn’s Disease to Fuel Demand for Novel Therapeutics

The rise in the incidence of Crohn’s diseases and ulcerative colitis is a major factor boosting the global inflammatory bowel diseases therapeutics market growth. Additionally, the rise in adoption of anti-inflammatory drugs and increasing demand for preventive care to avoid related disorders such as cancer is prognosticated to promote the global inflammatory bowel diseases therapeutics market growth in the future. Nearly 1.3% of adults in the U.S. were diagnosed with inflammatory bowel diseases such as ulcerative colitis or crohn’s disease in 2015, as per the Centre for Diseases Control and Prevention (CDC).. All mentioned factors are likely to boost the global inflammatory bowel disease therapeutics market.

Rise in Adoption of Sedentary Lifestyle to Help Market Grow Rapidly in Asia Pacific

The rise in prevalence of inflammatory bowel disease is anticipated to help North America emerge dominant in the global market. In addition, the increasing expenditure on healthcare and medical activities and availability of early diagnostic procedures for curing inflammatory diseases may also help this region to grow at high CAGR in the forecast period.

On the other hand, the market in Asia Pacific is anticipated to show high growth potential on account of the increasing prevalence of ulcerative colitis and crohn’s disease. Moreover, increasing risk factors related to inflammatory diseases such as consuming non-nutritious food, adoption of sedentary lifestyle, drinking, smoking, and others are also expected to boost the regional market in the forecast period.

Leading Players operating in the Inflammatory Bowel Diseases Therapeutics Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • GlaxoSmithKline Plc and Merck & Co., Inc.
  • AbbVie Inc.
  • Janssen Pharmaceuticals, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Shire

Segmentation of the Global Inflammatory Bowel Diseases Therapeutics Market

By Product

  • TNF inhibitors
  • Aminosalicylates
  • Immunomodulators
  • Corticosteroids
  • Others

By Disease Indication

  • Crohn’s Disease
  • Ulcerative Colitis
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Have Any Query? Ask Our Experts:

Report Focus:

  • Extensive product offerings
  • Customer research services
  • Robust research methodology
  • Comprehensive reports
  • Latest technological developments
  • Value chain analysis
  • Potential Inflammatory Bowel Diseases Therapeutics Market opportunities
  • Growth dynamics
  • Quality assurance
  • Post-sales support
  • Regular report updates

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Linkedin | Twitter | BLogs


Related Reports :

Acne Treatment Market

Acne Treatment Market Size

Acne Treatment Market Share

Acne Treatment Market Trends

Acne Treatment Market Growth

Acne Treatment Market Analysis

Fitness Tracker Market Business Opportunities

Fitness Tracker Market Key Players

Fitness Tracker Market Demand

Fitness Tracker Market Competitive Landscape

Fitness Tracker Market Segments

Fitness Tracker Market Overview

Leave a Reply

Your email address will not be published. Required fields are marked *